Home Keys to Success in Medicine Cardiovascular System Respiratory System Locomotor System Endocrine and Metabolic System Kidneys and Urinary System Gastrointestinal Tract Central Nervous System Haematological System Integumental System Reproductive and Genital System Analysing Medical Investigations Recommended Reading Forum Links
amazon astore
ydr
aces for paces
Clinical Skills Blogspot
Chronic Hepatitis C infection Title Ñ Chronic Hepatitis C infection Definition Ñ Chronic infection With the: Ñ Hepatitis C virus Aetiology Ñ RNA virus (Flavivirus) Ñ 6 Genotypes Pathogenesis Transmission Ñ Blood and blood products Ñ Intravenous drug abuse Ñ Limited role of sexual transmission in long-term heterosexual relationships Ñ Increased risk in homosexuals Ñ Vertical transmission from mother to child uncommon Ñ 20% mode of transmission unknown Aggravating factors The course of the illness is adversely affected by: Ñ Alcohol consumption Ñ Male sex Ñ Acquiring infection after the age of 40 years Ñ Genotype 1 or 4 Pathological Process Ñ Chronic hepatitis in > 50 % of those infected Ñ Half progress to cirrhosis Clinical Features Ñ Most acute infections are asymptomatic Ñ 10 % of patients have a flu like illness with jaundice and elevated serum aminotransferases E&M Ñ Higher incidence of diabetes mellitus Ñ Fatigue IS Ñ Porphyria cutanea tarda GIT Ñ Abnormal serum aminotransferases Ñ Chronic liver disease KUS Ñ Glomerulonephritis associated with cryoglobulinaemia LMS Ñ Arthritis Ñ Sjögren’s syndrome Complications GIT Ñ Cirrhosis of the liver Ñ Hepatocellular carcinoma Investigations Fluids Blood Microbiology Ñ HCV RNA: May be detected 1 or 2 weeks after infection Ñ Anti-HCV antibody: Usually positive 6 weeks after infection Management Cure Drugs Ñ Ribavarin Biological Agents Ñ Pegylated interferon Support Biological Agents Ñ Liver transplantation for end stage cirrhosis Prognosis Ñ Genotype 1 is the most difficult to treat
Chronic Hepatitis C infection
Title
Ñ Chronic Hepatitis C infection
Definition
Ñ Chronic infection
With the:
Ñ Hepatitis C virus
Aetiology
Ñ RNA virus (Flavivirus)
Ñ 6 Genotypes
Transmission
Ñ Blood and blood products
Ñ Intravenous drug abuse
Ñ Limited role of sexual transmission in long-term heterosexual relationships
Ñ Increased risk in homosexuals
Ñ Vertical transmission from mother to child uncommon
Ñ 20% mode of transmission unknown
Aggravating factors
The course of the illness is adversely affected by:
Ñ Alcohol consumption
Ñ Male sex
Ñ Acquiring infection after the age of 40 years
Ñ Genotype 1 or 4
Pathological Process
Ñ Chronic hepatitis in > 50 % of those infected
Ñ Half progress to cirrhosis
Clinical Features
Ñ Most acute infections are asymptomatic
Ñ 10 % of patients have a flu like illness with jaundice and elevated serum aminotransferases
E&M
Ñ Higher incidence of diabetes mellitus
Ñ Fatigue
IS
Ñ Porphyria cutanea tarda
GIT
Ñ Abnormal serum aminotransferases
Ñ Chronic liver disease
KUS
Ñ Glomerulonephritis associated with cryoglobulinaemia
LMS
Ñ Arthritis
Ñ Sjögren’s syndrome
Complications
Ñ Cirrhosis of the liver
Ñ Hepatocellular carcinoma
Investigations
Blood
Microbiology
Ñ HCV RNA:
May be detected 1 or 2 weeks after infection
Ñ Anti-HCV antibody:
Usually positive 6 weeks after infection
Management
Drugs
Ñ Ribavarin
Biological Agents
Ñ Pegylated interferon
Support
Ñ Liver transplantation for end stage cirrhosis
Prognosis
Ñ Genotype 1 is the most difficult to treat
[ Back ] [ Up ] [ Next ]
[Up]
